The ASAP1 protein is also overexpressed in 80% of primary prostate cancers, in which its expression is substantially higher in metastatic lesions; and moreover, additional copies of its gene are detected in 58% of primary prostate cancer specimens (44). This evidence concerns the gene ASAP1 and prostate cancer.